Click Here to return To Results

 

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease AJNR 31:347-354, Walhovd, K.B.,et al, 2010 See this aricle in Pubmed Article Abstract All biomarkers were sensitive to the diagnostic group. Combining MR imaging morphometry and CSF biomarkers improved diagnostic classification (controls versus AD). MR imaging morphometry and PET were largely overlapping in value of discrimination. Baseline MR imaging and PET measures were more predictive of clinical change in MCI than were CSF measures.

Related Tags

(click to filter results - removes previous filter) Alzheimer's disease biologic markers CAT scan,emission CAT scan,emission,abnormal cerebrospinal fluid,biochemical markers of CNS disease hippocampal atrophy hippocampus MRI,abnormal MRI,volumetry MRI,voxel-based morphometry neurologic disease,diagnoses of prognosis tau protein

Click Here to return To Results